| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/26/2011 | CN101959881A 5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use |
| 01/26/2011 | CN101959878A Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 01/26/2011 | CN101959876A 2-aminoquinolines |
| 01/26/2011 | CN101959864A 2-aminoquinoline derivatives |
| 01/26/2011 | CN101959855A Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 01/26/2011 | CN101959846A Novel salts of O-desmethyl-venlafaxine |
| 01/26/2011 | CN101959557A 2-aminoquinolines as 5-HT5A receptor antagonists |
| 01/26/2011 | CN101959529A Methods of treating inflammatory pain |
| 01/26/2011 | CN101959528A Methods of treating chronic pain |
| 01/26/2011 | CN101959513A Novel pharmaceutical compositions |
| 01/26/2011 | CN101957346A Novel method for studying medicament metabolism by using model organism zebrafish |
| 01/26/2011 | CN101955875A Gingko health wine and preparation method thereof |
| 01/26/2011 | CN101955543A Nerve growth factor bound with laminin, and coding gene and application thereof |
| 01/26/2011 | CN101955505A Novel immune suppressor and composition thereof |
| 01/26/2011 | CN101955470A Potentiators of glutamate receptors |
| 01/26/2011 | CN101955459A Method for preparing blonanserin |
| 01/26/2011 | CN101955440A Novel crystal form of agomelatine and preparation method thereof |
| 01/26/2011 | CN101954107A Solid aromatic sleep aid and preparation method thereof |
| 01/26/2011 | CN101954083A Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6S)-tetrahydrofolate |
| 01/26/2011 | CN101954066A Medicament for promoting repair of peripheral nerve injury |
| 01/26/2011 | CN101954054A medical composite used for curing insomnia |
| 01/26/2011 | CN101954039A Traditional Chinese medicinal decoction for treating insomnia |
| 01/26/2011 | CN101954038A Chine medicament for treating insomnia |
| 01/26/2011 | CN101954031A Medicament for treating vascular dementia and preparation method |
| 01/26/2011 | CN101954025A Traditional Chinese medicine for treating diabetic acro-necrosis |
| 01/26/2011 | CN101954024A Traditional Chinese medicament for treating diabetic foot |
| 01/26/2011 | CN101954006A Chinese medicament for treating insomnia |
| 01/26/2011 | CN101954004A Medicament for treating insomnia |
| 01/26/2011 | CN101953999A Medicinal composition for treating paralysis and preparation method thereof |
| 01/26/2011 | CN101953967A Infantile cerebral palsy capsule |
| 01/26/2011 | CN101953963A Traditional Chinese medicinal preparation for treating brain and renal function failure |
| 01/26/2011 | CN101953959A Chinese medicament for treating diabetic gastroparalysis |
| 01/26/2011 | CN101953957A Traditional Chinese medicinal formula for treating insomnia |
| 01/26/2011 | CN101953955A Traditional Chinese medicament for treating diabetic peripheral neuropathy |
| 01/26/2011 | CN101953933A Smoking quitting tea |
| 01/26/2011 | CN101953921A Traditional Chinese medicinal formula for treating insomnia |
| 01/26/2011 | CN101953918A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 01/26/2011 | CN101953887A Medicinal composition for preventing and treating diabetic complications and preparation method thereof |
| 01/26/2011 | CN101953864A Cynanchum otophyllum aglycone and medical application of extractive containing same |
| 01/26/2011 | CN101953857A Compound fermented cordyceps sinensis bacterium powder (paecilomyces hepiali Cs-4 bacterium powder) composite medicine |
| 01/26/2011 | CN101953833A Slowly-controlled release formulation containing rizatriptan benzoate, preparation method and application thereof |
| 01/26/2011 | CN101953831A Buflomedil hydrochloride medicinal composition used for injection |
| 01/26/2011 | CN101953822A Venlafaxine hydrochloride controlled release tablets and preparation method thereof |
| 01/26/2011 | CN101953819A Improved transdermal delivery system for administration of rotigotine |
| 01/26/2011 | CN101953811A Pill composition used for preventing and treating Alzheimer disease and preparation method thereof |
| 01/26/2011 | CN101953810A Breviscapine pill |
| 01/26/2011 | CN101953768A Smoking-cessation toothpaste |
| 01/26/2011 | CN101953601A Novel throw pillow |
| 01/26/2011 | CN101953513A Nanometer element anion far-infrared fabric underwear for preventing and treating brain dementia |
| 01/26/2011 | CN101953512A Coffee cigarette and preparation method thereof |
| 01/26/2011 | CN101953449A Method for preparing albizziae flower porridge |
| 01/26/2011 | CN101450189B Medicine for curing angiocardiopathy and cerebrovascular disease and its preparing method |
| 01/26/2011 | CN101396490B Traditional Chinese medicine for treating headache of the blood vessel |
| 01/26/2011 | CN101274911B Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| 01/26/2011 | CN101249219B Paste for curing idiopathic facial nerve paralysis disease and preparation method thereof |
| 01/26/2011 | CN101234188B Pharmaceutical composition for treating pain and preparation thereof |
| 01/26/2011 | CN101040863B Medicine monocase compound for treating alzheimers disease |
| 01/26/2011 | CN101002827B Micro-emulsion of mint oil with slow-releasing property, and its preparing method |
| 01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/25/2011 | US7875652 Method and composition for treating pain or tinnitus aureum |
| 01/25/2011 | US7875633 Phenylpyridone derivative |
| 01/25/2011 | US7875632 combination of N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide andmonoamine oxidase inhibitor (MAO-I ) selected from tranylcypromine (Parnate), phenelzine (Nardil), maprotiline, and isocarboxazid (Marplan); anti-psychotic agent; dosage form; capsule |
| 01/25/2011 | US7875614 Phthalazinones |
| 01/25/2011 | US7875611 Ion channel modulating compounds and uses thereof |
| 01/25/2011 | US7875605 1-Benzenesulfonyl-3-(4-methylpiperazin-1-ylmethyl)-5-nitro-1 H-indole; 1-[[5-Bromo-1-(2-Bromo-4-methoxybenzenesulfonyl)-indo1-3-yl]methyl][1,4]diazepane; useful for treating psychotic and neurodegenerative disorders e.g. schizophrenia, Alzheimer's disease, Parkinson's disease and Huntington's chorea |
| 01/25/2011 | US7875585 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | US7875259 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 01/25/2011 | CA2628200C Solid pharmaceutical compositions containing pregabalin |
| 01/25/2011 | CA2599158C Pharmaceutical agent comprising solifenacin |
| 01/25/2011 | CA2540247C Prodrugs of amino acids with affinity for the .alpha.2.delta.-protein |
| 01/25/2011 | CA2506648C 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 01/25/2011 | CA2490141C 1-[(indol-3-yl)carbonyl]piperazine derivatives |
| 01/25/2011 | CA2476983C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
| 01/25/2011 | CA2468681C Adenosine a2a receptor antagonists |
| 01/25/2011 | CA2468673C Compounds specific to adenosine a1 and a3 receptors and uses thereof |
| 01/25/2011 | CA2463146C Crystalline sodium salt of telmisartan and the use of same as an angiotensin antagonist |
| 01/25/2011 | CA2458690C Pharmaceutical compositions comprising an ascomycin derivative |
| 01/25/2011 | CA2449066C Nicotine-containing film preparation |
| 01/25/2011 | CA2447765C 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 01/25/2011 | CA2443868C 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
| 01/25/2011 | CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/25/2011 | CA2339834C Water soluble prodrugs of hindered alcohols or phenols |
| 01/25/2011 | CA2334200C Pyrrolo[2,3d]pyrimidine compositions and their use |
| 01/25/2011 | CA2317455C Hydroxamic and carboxylic acid derivatives |
| 01/25/2011 | CA2175429C Pharmaceutical compositions and methods |
| 01/25/2011 | CA2174098C Method of inducing and maintaining neuronal cells |
| 01/21/2011 | CA2709551A1 New piperidine compounds, their preparation process and the pharmaceutical compositions containing these compounds |
| 01/21/2011 | CA2709341A1 New chromene derivatives, their preparation process and the pharmaceutical compositions containing these derivatives |
| 01/20/2011 | WO2011009102A1 Use of a melatonin agonist for the treatment of sleep disorders including primary insomnia |
| 01/20/2011 | WO2011009097A2 Methods for treating schizophrenia |
| 01/20/2011 | WO2011009061A1 Compositions comprising a cholinesterase inhibitor for treating cognitive disorders |
| 01/20/2011 | WO2011009015A1 (+) - morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof |
| 01/20/2011 | WO2011008709A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | WO2011008686A1 Exo-s-mecamylamine method, use, and compound for treatment |
| 01/20/2011 | WO2011008675A2 Catecholamine compounds, compositions, and formulations, and methods of using the same |
| 01/20/2011 | WO2011008636A1 3-oxy-hydromorphone derivatives |
| 01/20/2011 | WO2011008585A2 Methods and compositions for protecting and treating neuroinjury |